Abstract
How best to evaluate scientists within a peer group is a difficult task. This editorial discusses the use of the H-index and total citations. It also raises the consideration of a mentoring-index and the value of understanding the frequency that a published paper is accessed by readers.
Editorial
Key performance indicators
A challenging question in peer-reviewed science is how to distribute judiciously resources amongst a large number of competing researchers. What are the "key performance indicators" that should be used to evaluate scientists who pursue similar research interests? One popular discussion is to ask how many times a person has published articles in journals with a high impact factor (IF). Several "quirks" in the way that a journal's IF is calculated have prompted many individuals to question whether this number reliably reflects the citation frequency of research articles that are published in the journal [1]. Recently, a scientist's H-index (HI) [2] has been suggested as a more informative measure of his/her scientific productivity [1].
H-index and total citations
The predictive value of the HI does have limitations [3]. However, in a 2007 survey of Retrovirology editorial board members, it was noted that an individual's H-number correlated well with the absolute frequency that his/her published papers were cited in the scientific literature [1]. A mid-October 2008 update of the 2007 survey, using numbers from the Scopus database http://www.scopus.com, continues to support this correlation (Table 1). Thus, within a well-delimited field of research, a scientist's HI and his/her total citations appear to be reasonably quantitative peer-measures, seemingly superior to the colloquial banters about "high impact" papers. It should be noted that different databases measure HI numbers over varying time periods, and are not directly comparable. In general, a HI number increases with the length of time over which it is measured; hence, older scientists would usually be expected to sport HI numbers higher than their younger counterparts
Table 1.
Title | Name | Role within Retrovirology | Institution | City | Country | H index | Total times cited since 1996 |
Dr. | Kuan-Teh Jeang | Editor-in-Chief | NIH | Bethesda | USA | 43 | 9082 |
Dr. | Monsef Benkirane | Editor | CNRS | Montpellier | France | 20 | 1751 |
Dr. | Ben Berkhout | Editor | Academic Med. Ctr | Amsterdam | the Netherlands | 38 | 6022 |
Dr. | Andrew ML Lever | Editor | Cambridge University | Cambridge | UK | 19 | 1919 |
Dr. | Mark Wainberg | Editor | McGill University | Montreal | Canada | 39 | 9519 |
Dr. | Masahiro Fujii | Editor | Niigata University | Niigata | Japan | 19 | 1686 |
Dr. | Michael Lairmore | Editor | Ohio State University | Columbus | USA | 20 | 1933 |
Dr. | Michael Bukrinsky | Ed Board | George Washington Univ | Washington DC | USA | 25 | 4913 |
Dr. | Dong-yan Jin | Ed Board | Hong Kong U | Hong Kong | China | 22 | 2402 |
Dr. | Klaus Strebel | Ed Board | NIH | Bethesda | USA | 25 | 3889 |
Dr. | Tom J. Hope | Ed Board | U. Illinois | Chicago | USA | 26 | 4307 |
Dr. | Ariberto Fassati | Ed Board | University College | London | England | 11 | 524 |
Dr. | Stephane Emiliani | Ed Board | Cochin Institute | Paris | France | 17 | 1774 |
Dr. | Patrick Green | Ed Board | Ohio State | Columbus | USA | 17 | 918 |
Dr. | Mauro Giacca | Ed Board | Int. Ctr. Genetics | Trieste | Italy | 35 | 5051 |
Dr. | Olivier Schwartz | Ed Board | Institut Pasteur | Paris | France | 27 | 3657 |
Dr. | Leonid Margolis | Ed Board | National Inst Child Health | Bethesda | USA | 22 | 1745 |
Dr. | Fatah Kashanchi | Ed Board | George Washington U. | Washington DC | USA | 26 | 2503 |
Dr. | Masao Matsuoka | Ed Board | Kyoto University | Kyoto | Japan | 24 | 1992 |
Dr. | Naoki Mori | Ed Board | University of the Ryukyus | Okinawa | Japan | 24 | 1982 |
Dr. | Chou-Zen Giam | Ed Board | Uniform Services Med School | Bethesda | USA | 14 | 1454 |
Dr. | David Derse | Ed Board | NCI | Frederick | USA | 13 | 1667 |
Dr. | Tatsuo Shioda | Ed Board | Osaka Univ | Osaka | Japan | 24 | 1956 |
Dr. | John Semmes | Ed Board | Eastern Virginia Med College | Norfolk | USA | 27 | 2953 |
Dr. | Anne Gatignol | Ed Board | McGill Univ. | Montreal | Canada | 14 | 1012 |
Dr. | Rogier Sanders | Ed Board | Academic Med Ctr. | Amsterdam | the Netherlands | 13 | 845 |
Dr. | Chen Liang | Ed Board | McGill Univ. | Montreal | Canada | 19 | 915 |
Dr. | Finn Skou Pedersen | Ed Board | University of Aarhus | Aarhus | Denmark | 19 | 1490 |
Dr. | Janice Clements | Ed Board | Johns Hopkins Med School | Baltimore | USA | 23 | 3454 |
Dr. | Renaud Mahieux | Ed Board | Pasteur Inst | Paris | France | 23 | 1312 |
Dr. | Chris Aiken | Ed Board | Vanderbilt University | Nashville | USA | 18 | 2347 |
Dr. | Neil Almond | Ed Board | NIBSC | Potters Bar | UK | 12 | 1121 |
Dr. | Stephen P. Goff | Ed Board | Columbia University | New York | USA | 41 | 13771 |
Dr. | Johnson Mak | Ed Board | Burnet Inst. Med. Research | Victoria | Australia | 15 | 1298 |
Dr. | Christine Kozak | Ed Board | NIH | Bethesda | USA | 29 | 7489 |
Dr. | Greg Towers | Ed Board | University College | London | UK | 17 | 1392 |
Dr. | Graham Taylor | Ed Board | Imperial College | London | UK | 15 | 1567 |
Dr. | Eric Cohen | Ed Board | Univ. Montreal | Montreal | Canada | 27 | 3221 |
Dr. | William Hall | Ed Board | University College Dublin | Dublin | Ireland | 21 | 2071 |
Dr. | Warner Greene | Ed Board | UCSF | San Francisco | USA | 39 | 10133 |
Dr. | Jean-luc Darlix | Ed Board | U. Lyon | Lyon | France | 32 | 5654 |
Dr. | Axel Rethwilm | Ed Board | U. Wuerzburg | Wuerzburg | Germany | 22 | 2040 |
Dr. | Eric Freed | Ed Board | NCI | Frederick | USA | 29 | 4415 |
Dr. | Toshiki Watanabe | Ed Board | Univ. of Tokyo | Tokyo | Japan | 22 | 2167 |
Dr. | Mari Kannagi | Ed Board | Tokyo Med and Dental U | Tokyo | Japan | 15 | 1350 |
Dr. | Frank Kirchhoff | Ed Board | University of Ulm | Ulm | Germany | 30 | 4520 |
Dr. | Jennifer Nyborg | Ed Board | Colorado State U | Fort Collins | USA | 17 | 1571 |
Dr. | Akifumi Takaori-Kondo | Ed Board | Kyoto University | Kyoto | Japan | 13 | 589 |
Dr. | Marc Sitbon | Ed Board | CNRS | Montpellier | France | 12 | 690 |
Dr. | Paul Gorry | Ed Board | MacFarlane Burnet Institute | Melbourne | Australia | 13 | 607 |
Dr. | David Harrich | Ed Board | Queensland Inst Medical Res. | Brisbane | Australia | 12 | 1000 |
Dr. | Susan Marriott | Ed Board | Baylor | Houston | USA | 14 | 1021 |
Dr. | Damian Purcell | Ed Board | U Melbourne | Melbourne | Australia | 12 | 902 |
Dr. | Alan Cochrane | Ed Board | U Toronto | Toronto | Canada | 10 | 1080 |
Dr. | Yiming Shao | Ed Board | China CDC | Beijing | China | 13 | 977 |
Dr. | Vinayaka Prasad | Ed Board | Albert Einstein College Medicine | New York | USA | 18 | 1187 |
A time for a mentoring-index?
Scientists do research and also mentor younger colleagues. Good mentoring should be a significant consideration of one's contribution to science. The HI might measure research productivity, but currently there does not appear to be a "mentoring index" (MI). Accepting that mentoring is an important component of a scientist's career, one could propose to construct a MI derived as a composite value based on the current HI of trainees during an earlier period with a given mentor. For example, a MI for scientist X reflecting his/her mentoring influence during the 1991 to 1995 period could be calculated from the sum of today's HI for all the first authors from his/her laboratory on papers published during 1991 to 1995 with scientist X as the last author. As an example, for Kuan-Teh Jeang (KTJ) during the 1991–1995 period, there were eight different first authors who listed the same laboratory affiliation as KTJ and who published papers with KTJ as the last author. The eight individuals, (with current HI in parentheses) A. Gatignol (14), B. Berkhout (38), B. Dropulic (9). O.J. Semmes (27), Y.N. Chang (5), F. Majone (5), A. Joshi (2) and L.M. Huang (19), provide a total HI of 14 + 38 + 9 + 27 + 5 + 5 + 2 + 19 = 119. If one divides 119 by 8, a MI of 14.8 for KTJ is derived. This number could be used for comparing KTJ to others for mentoring contributions during a defined period (e.g. 1991 to 1995). Of course, comparisons are meaningful only when done amongst appropriate peer groups. A focus on using the HI of previous trainees in evaluating established scientists could encourage the development of long-lasting mentoring relationships that continue even after the trainees have departed the mentors' laboratories.
Frequency of citation versus frequency of access
The above discussions of HI, MI, citation frequencies, and impact factor presume the primacy of citations as a measure of scientific value. What if this presumption is off-the-mark? Is there another value that could be considered? In other areas of communication (book publishing, music distribution) where citation metrics are irrelevant, the numbers of readers (copies of books sold) and listeners (number of albums sold or songs downloaded) are used to gauge impact. In the modern internet era, the frequency of "hits" or accesses to portals such as YouTube or Facebook quantitatively gauges relative importance. In this respect, should the frequency of accesses to online Open Access scientific articles similarly matter? To begin to explore this question, I examined the top 15 "all time" most highly accessed papers at Retrovirology http://www.retrovirology.com/mostviewedalltime. In this dataset, four 2006 papers (excluding a meeting report, [4]) were identified that have been accessed 23,634; 8,592; 8,304; and 7,902 times respectively [5], [6], [7], [8]. These four highly accessed papers have been cited to date 14, 13, 15, and 14 times, placing them in the top 15% of cited Retrovirology papers published in 2006. On the other hand, the four Retrovirology papers published during 2006 that are currently the most frequently cited [9], [10], [11], [12] (cited 27, 23, 21, 20 times) are not the four which are the most highly accessed. Thus, high readership does seem to produce high citation frequency, but high citation frequency does not always require high readership. This pattern suggests that Open Access readers encompass those who simply read and those who read and also write papers that cite other papers. Citation numbers measure the latter group, while access numbers measure both groups. Arguably, it is unclear that a published paper's influence on one group (citations) counts while the less well-tabulated impact on the second group (accesses) counts not. The relative merits of citations versus accesses require further validation.
Acknowledgements
I thank Mark Wainberg, Andrew Lever, and Ben Berkhout for critical readings of this editorial. The values shown in Table 1 are to be viewed as illustrative examples and are not to be regarded as fully accurate. The views expressed are the author's personal opinion and do not represent the position of the author's employer, the National Institutes of Health, USA. Research in KTJ's laboratory is supported by NIAID Intramural funds. I thank Christina Bezon for assistance with Table 1.
Competing interests
The author declares that he has no competing interests.
Acknowledgments
Authors' contributions
KTJ wrote this editorial.
References
- Jeang KT. Impact factor, H index, peer comparisons, and Retrovirology: is it time to individualize citation metrics? Retrovirology. 2007;4:42. doi: 10.1186/1742-4690-4-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hirsch JE. Does the H index have predictive power? Proc Natl Acad Sci USA. 2007;104:19193–19198. doi: 10.1073/pnas.0707962104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Honekopp J, Kleber J. Sometimes the impact factor outshines the H index. Retrovirology. 2008;5:88. doi: 10.1186/1742-4690-5-88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Freed EO, Mouland AJ. The cell biology of HIV-1 and other retroviruses. Retrovirology. 2006;3:77. doi: 10.1186/1742-4690-3-77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK. Host-virus interaction: a new role for microRNAs. Retrovirology. 2006;3 doi: 10.1186/1742-4690-3-68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weiss RA. The discovery of endogenous retroviruses. Retrovirology. 2006;3:67. doi: 10.1186/1742-4690-3-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ghafouri M, Amini S, Khalili K, Sawaya BE. HIV-1 associated dementia: symptoms and causes. Retrovirology. 2006;3:28. doi: 10.1186/1742-4690-3-28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saumet A, Lecellier CH. Anti-viral RNA silencing: do we look like plants? Retrovirology. 2006;3:3. doi: 10.1186/1742-4690-3-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cavanagh MH, Landry S, Audet B, Arpin-André C, Hivin P, Paré ME, Thête J, Wattel E, Marriott SJ, Mesnard JM, Barbeau B. HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated. Retrovirology. 2006;3:15. doi: 10.1186/1742-4690-3-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cochrane AW, McNally MT, Mouland AJ. The retrovirus RNA trafficking granule: from birth to maturity. Retrovirology. 2006;3:18. doi: 10.1186/1742-4690-3-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Retrovirology. 2006;3:76. doi: 10.1186/1742-4690-3-76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marcello A. Latency: the hidden HIV-1 challenge. Retrovirology. 2006;3:7. doi: 10.1186/1742-4690-3-7. [DOI] [PMC free article] [PubMed] [Google Scholar]